These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10637007)

  • 1. Localization of experimental submucosal esophageal tumor in rabbits by using mono-L-aspartyl chlorin e6 and long-wavelength photodynamic excitation.
    Sheyhedin I; Okunaka T; Kato H; Yamamoto Y; Sakaniwa N; Konaka C; Aizawa K
    Lasers Surg Med; 2000; 26(1):83-9. PubMed ID: 10637007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic therapy of intestinal tumors with mono-L-aspartyl chlorin e6 (NPe6): a basic study.
    Kikuchi T; Asakura T; Aihara H; Shiraki M; Takagi S; Kinouchi Y; Aizawa K; Shimosegawa T
    Anticancer Res; 2003; 23(6C):4897-900. PubMed ID: 14981942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endovascular photodynamic therapy using mono-L-aspartyl-chlorin e6 to inhibit Intimal hyperplasia in balloon-injured rabbit arteries.
    Nagae T; Aizawa K; Uchimura N; Tani D; Abe M; Fujishima K; Wilson SE; Ishimaru S
    Lasers Surg Med; 2001; 28(4):381-8. PubMed ID: 11344521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot study of topical delivery of mono-L-aspartyl chlorin e6 (NPe6): implication of topical NPe6-photodynamic therapy.
    Wong TW; Aizawa K; Sheyhedin I; Wushur C; Kato H
    J Pharmacol Sci; 2003 Oct; 93(2):136-42. PubMed ID: 14578580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy with a diode laser for implanted fibrosarcoma in mice employing mono-L-aspartyl chlorin E6.
    Katsumi TA; Aizawa K; Kuroiwa Y; Saito K; Kurata Y; Ii Y; Okunaka T; Konaka C; Kato H
    Photochem Photobiol; 1996 Oct; 64(4):671-5. PubMed ID: 8863472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Potential of photodynamic therapy with a second-generation sensitizer: mono-L-aspartyl chlorin e6].
    Mori K; Ohta M; Sano A; Yoneya S; Sonoda M; Kaneda A; Sato Y
    Nippon Ganka Gakkai Zasshi; 1997 Feb; 101(2):134-40. PubMed ID: 9124093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model.
    Wong Kee Song LM; Wang KK; Zinsmeister AR
    Cancer; 1998 Jan; 82(2):421-7. PubMed ID: 9445202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy with mono-L-aspartyl chlorin e6 can cause necrosis of squamous cell carcinoma of tongue: experimental study on an animal model of nude mouse.
    Kobayashi W; Liu Q; Nakagawa H; Sakaki H; Teh B; Matsumiya T; Yoshida H; Imaizumi T; Satoh K; Kimura H
    Oral Oncol; 2006 Jan; 42(1):46-50. PubMed ID: 16266818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transadventitial localisation of atheromatous plaques by fluorescence emission spectrum analysis of mono-L-aspartyl chlorin e6.
    Hayashi J; Kuroiwa Y; Sato H; Saito T; Aizawa K
    Cardiovasc Res; 1993 Nov; 27(11):1943-7. PubMed ID: 8287401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase-resolved fluorescence study of mono-L-aspartyl chlorin E6.
    Li L; Kodama K; Saito K; Aizawa K
    J Photochem Photobiol B; 2002 May; 67(1):51-6. PubMed ID: 12007467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy using mono-L-aspartyl chlorin e6 for rabbit experimental hepatoma.
    Nakamura J; Kajiwara H
    J Hepatobiliary Pancreat Surg; 1999; 6(3):312-9. PubMed ID: 10526068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraocular biodistribution of mono-L-aspartyl chlorin e6 in a primate choroidal neovascularization model.
    Mori K; Kanai K; Peyman GA; Yoneya S
    Ophthalmic Surg Lasers Imaging; 2007; 38(2):142-7. PubMed ID: 17396695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence properties of a hydrophilic sensitizer in pigmented rats, rabbits, and monkeys.
    Moshfeghi D; Peyman GA; Kazi AA; Unal M; Khoobehi B; Yoneya S; Mori K
    Ophthalmic Surg Lasers; 1999; 30(9):750-3. PubMed ID: 10574497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces.
    Chan AL; Juarez M; Allen R; Volz W; Albertson T
    Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):72-8. PubMed ID: 15752124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy of experimental choroidal neovascularization with a hydrophilic photosensitizer: mono-L-aspartyl chlorin e6.
    Mori K; Yoneya S; Anzail K; Kabasawa S; Sodeyama T; Peyman GA; Moshfeghi DM
    Retina; 2001; 21(5):499-508. PubMed ID: 11642380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study.
    Taber SW; Fingar VH; Coots CT; Wieman TJ
    Clin Cancer Res; 1998 Nov; 4(11):2741-6. PubMed ID: 9829737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photosensitizing properties of mono-L-aspartyl chlorin e6 (NPe6): a candidate sensitizer for the photodynamic therapy of tumors.
    Spikes JD; Bommer JC
    J Photochem Photobiol B; 1993 Feb; 17(2):135-43. PubMed ID: 8459317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of photodynamic therapy using mono-L-aspartyl chlorin e6 on vessels and its contribution to the antitumor effect.
    Saito K; Mikuniya N; Aizawa K
    Jpn J Cancer Res; 2000 May; 91(5):560-5. PubMed ID: 10835502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-aspartyl chlorin e6).
    Mori K; Yoneya S; Ohta M; Sano A; Anzai K; Peyman GA; Moshfeghi DM
    Ophthalmology; 1999 Jul; 106(7):1384-91. PubMed ID: 10406627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy using a diode laser with mono-L-aspartyl chlorin e6 for implanted fibrosarcoma in mice.
    Katsumi T; Aizawa K; Okunaka T; Kuroiwa Y; Ii Y; Saito K; Konaka C; Kato H
    Jpn J Cancer Res; 1994 Nov; 85(11):1165-70. PubMed ID: 7829403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.